Search Results

Clinical trials are the bedrock of discovery for promising cancer treatments, and even cures. Without proper access for underrepresented populations, health care disparities persist. Recognizing this, some states have taken action to toward coverage of routine care during clinical trials for all.

According to the Centers for Disease Control and Prevention (CDC), tobacco is the leading cause of preventable death. Tobacco-related diseases, including lung cancer, are responsible for 480,000 deaths each year in the United States.Many states are raising the age to purchase tobacco products to 21, but the widespread availability of vaping products and their popularity among young people present new challenges to legislators.

Research has shown that patients with cancer and cancer survivors are at increased risk of severe illness and death if they are infected with COVID-19. In several states, AACI cancer centers are leading an effort to prioritize these vulnerable populations for the COVID-19 vaccine.

In June 2023 Louisiana Governor John Bel Edwards signed into law a new bill aimed at broadening Medicaid coverage for chimeric antigen receptor T-cell (CAR T) therapy.

Gender-neutral vaccination of children, aged 11-12, has been proven effective in preventing HPV and related cancers, including oropharyngeal, cervical, anal, vulvar, penile, and vaginal cancers.

Recommendations from trusted health care providers are one of the most effective interventions for preventing HPV infection and HPV-related cancers.

Armed with the knowledge that tobacco-related diseases, including lung cancer, are responsible for 480,000 deaths each year in the United States, many states are raising the age to purchase tobacco products to 21 to curb youth tobacco use and diminish long-term health effects.

Scientific evidence has shown negative effects of electronic cigarette flavoring agents on the lungs, and deaths have been reported. The widespread availability of vaping products and their popularity among young people present new challenges to legislators and public health advocates.

Recognizing the pervasive health effects of both combustible tobacco and vaping products, some states have proposed legislation that broadly addresses tobacco-related public health issues.

UCSF Helen Diller Family Comprehensive Cancer Center A study of more than 2,000 men with localized prostate cancer found that eating a primarily plant-based diet was associated with a 47 percent lower risk that their cancer would progress compared with those who consumed the most animal products. Men with prostate cancer could significantly reduce the chances of the disease worsening by eating more fruits, vegetables, nuts, and olive oil, according to new research by UC San Francisco.

This Bill will address economic barriers to participation in clinical trials by:Exempting free digital health technology that enables trial participation from the Anti-Kickback statute when doing so will facilitate clinical trial participation by underrepresented populations;Allowing patient cost-sharing by a drug or device manufacturer in a clinical trial when specific criteria are met;Excluding remuneration for participation in clinical trials from taxable income.

Cellular Therapy Initiative (CTI) steering committee members have designed a series of narrated educational slide decks to help increase patient referrals for CAR T therapy in the community. 

The PCLI steering committee produces quarterly webinars on a variety of topics with invited speakers who share their expertise. 

In 2023, Washington State Governor Jay Inslee signed WA HB1745 into law. This bill has the goal of increasing diversity in clinical trials by addressing systemic barriers that can limit participation. This bill adds a requirement that any state entity or hospital receiving funding from the National Institutes of Health must take the following steps to update their clinical trials conduct

The 2025 AACI Catchment Area Data Excellence (CADEx) Conference will be held January 29-31 in Coronado, CA. This three-day event will bring together cancer center catchment area data experts, geospatial statisticians, and representatives from government and industry to address emerging topics in cancer prevention and control analytics. Attendees will share best practices in data collection, explore policies and methodologies to advance catchment area cancer surveillance, build relationships to …